This company is targeting the medical wearable market, Google, Stanford, Reckitt Benckiser are its partners

In recent years, medical devices are going to the family, medical scenes are also extended to the family, health smart wearable devices is the extension of the tentacles, it is intelligent, miniaturized to meet the needs of consumer health management, and big data, AI and other technologies, began to play a role in the health risk assessment, intelligent early warning, personalized health management, and become the entrance to the Internet of Things ecosystem.

Ahadome, a market research organization, predicted that the application of smart wearable devices in the field of medical and health care will become mainstream, accounting for more than 50% of the total. 2012 is also known as the "first year of wearable devices", but many of the products have been reduced to "toys". "

What's more, it's not just about the way you look at it.

If you want to have more say in the medical field, wearable devices need to enter the medical core, with more irreplaceable.

Companies that want to break through the barriers to enter the medical center are many, Apple in the Apple watch launched with ECG monitoring products certified by the FDA, there are also listed in 2016 market value of $ 891 million iRhythm.

In most of the products are still in the absence of authoritative certificates, drowning in the bubble of homogenization, the arterial network found that VivaLNK ( Reckitt&Benckiser to successfully commercialize the product worldwide.

On top of the basic technology platform, VivaLNK has launched the Developer Program for the global market in order to build the Internet of Healthcare Things (IoHT) ecosystem with partners***. Currently, VivaLNK is working with AlacrityCare and Myia to help innovate remote diagnosis and treatment of cancer and cardiovascular disease.

In addition to providing clinical solutions for cancer and cardiovascular disease, VivaLNK has also partnered with Stanford University and Case Western Reserve University to conduct research on stress management.

How will VivaLNK, with its underlying technology platform development and integrated hardware and software development capabilities, become the backbone of innovative healthcare? In this regard, Arterial Network interviewed Dr. Li Jiang, Founder and CEO of VivaLNK and National Thousand Talent Expert, and Ms. Xu Lei, Marketing Spokeswoman of VivaLNK.

Enhancing the quality of sign data with leading sensors and algorithms

With its self-developed and disruptive eSkin medical sensing technology and advanced medical cloud AI data analytics, VivaLNK is committed to realizing multi-vital parameter monitoring and sign analysis for the Internet of Things (IoT) in the field of healthcare through medical-grade wearables. The company is committed to providing its market partners with comprehensive solutions for health management, patient monitoring, and remote care through medical-grade wearable devices that enable the monitoring of multiple life parameters and the analysis of signs and symptoms in the medical IoT field.

Currently, VivaLNK's three main products are the Fever Scout temperature monitoring patch, the Vital Scout health monitoring patch, and the ECG monitoring patch. These three products are based on VivaLNK's unique eSkin? medical sensing technology, which improves the quality of dynamic life data management through soft wearable patches and real-time monitoring of vital signs. It is a goodbye to traditional devices that cannot be continuously monitored, bulky and heavy, and also revolutionizes the lack of precision of wearable devices on the market.

Fever Scout is a medical device that can be attached to a child's armpit to achieve "zero distance" real-time temperature monitoring.

Xu Lei told Arterial.com, "Children's fever can easily lead to other diseases such as febrile convulsions, which require parents to observe their children's status in real time; and some post-surgical infections or other complications can also be indicated by temperature indicators. VivaLNK has partnered with AlacrityCare-type companies to effectively connect patients with caregivers during cancer treatment, to better understand changes in body temperature and other indicators throughout the treatment process, and to provide hospitals with clinical-grade monitoring solutions."

In addition to its temperature monitoring product line, VivaLNK has developed a range of products for heart rate and atrial fibrillation related health sign monitoring based on patented technology. VivaLNK's hardware has top-of-the-line sensors, and in terms of soft power, VivaLNK also has AI, cloud computing, and other technologies to support data integration and analysis.

Take Vital Scout, VivaLNK's health monitoring patch, for example, which helps consumers better manage their health through HR and HRV, or heart rate and heart rate variability (HRV refers to the variation in the difference between heartbeat cycles, which is a valuable indicator for predicting sudden cardiac death and arrhythmic events), together with professional algorithms in the background, and a small patch and app that can be attached to the chest to help users better manage their health.

With a small patch attached to the chest and an app, users can see indices of stress, sleep, exercise, recovery, and more on their terminals.

In terms of vital signs monitoring, VivaLNK uses patented chip and sensor technology and new material technology to achieve medical-grade data collection and integration, as well as the portability and intelligence of consumer products.

In addition to working with Google on the launch of the "e-skin" at the beginning of its life, VivaLNK has recently partnered with Stanford University to develop the Vital Scout health monitoring patch, which will be used by researchers in the Stanford Department of Psychiatry and Behavioral Sciences to track adolescent stress indices in real time and over time.

The Vital Scout health patch, developed by Veritas, will help researchers at Stanford's Department of Psychiatry and Behavioral Sciences to track adolescent stress and other key physiological parameters in real-time and over time, with the goal of exploring whether there is a correlation between stress levels and adolescent depression.

At the end of December, VivaLNK added a new partnership with Case Western Reserve University, a world-renowned institution of higher learning.

Case Western Reserve will utilize VivaLNK's equipment to measure the relationship between metrics and stress levels. Key metrics include heart rate, respiratory rate, sweat rate, and acute/chronic workload ratio, a well-established measure of athletic injury.

Constructing core barriers with patented sensor technology and intelligent computing technology

The demand for this market will be very large, and abroad, according to Arterial.com's 2018 Medical IoT Special Report, the global medical IoT will exceed $158 billion in 2022, with a compound annual growth rate of 2017~2022 of growth rate as high as 30.9%. Among them, sign monitoring, asset management, and personnel management have become the most applied scenarios of medical IoT.

Most of the earliest consumer-grade products that landed on vital signs monitoring have turned into bubbles, and the remaining ones are breaking out toward spiking consumer-grade products into medical-grade products.

Dr. Robert Pearl, CEO of Kaiser Permanente, has said, " The main reason health-grade wearables have struggled to catch on and spread is because the monitoring capabilities they provide are limited in accuracy on the one hand, and on the other hand, they don't offer the ability to provide follow-up medical interventions."

There is a solution to both of these problems, and that is for the data to be recognized by physicians and for the data to inform clinical decisions. Approval by the FDA can endorse the product on both counts.

In this regard in the landing of the head of the two companies, one is iRhythm, the second is the giant Apple. The two are also closely related, and iRhythm's stock price plummeted when Apple launched the Apple watch with ECG monitoring.

iRhythm's core product is a wearable device for rapid arrhythmia detection, the Zio@Patch. but the Zio@Patch can only be obtained by prescription, not real-time transmission of data, and after two weeks, the patient then mails the patch to iRhythm, where the data is analyzed on a cloud platform. It is finally sent to the user's doctor. Unable to realize the portable record of VIVALNK products and instant management and feedback on lifestyle.

For the user, only present data, little value, the device not only need to feedback interaction, but also need to propose solutions after the data is presented.

Dr. Li Jiang said: "Electronic skin has technical barriers to circuit design, structural design, packaging technology, signal processing and other aspects. Welling's upcoming ECG products can recognize atrial fibrillation, have functions such as data alerts and automatic monitoring, and can be reused to help users with lifestyle management."

Apple is also investing heavily in vital signs monitoring, and news reports have indicated that many people have had their lives saved by the Apple watch's abnormal heart rhythm alerts.

While Apple watch's FDA-cleared products are worth shouting about, they also represent a trend toward more precision in medical wearables. Currently the authoritative monitoring site in the hospital is near the heart, and data obtained at the wrist is usually reconfirmed.

Gathering IT and medical professionals to form a dream team to break down medical information silos

VivaLNK's ability to develop cutting-edge medical IoHT sensing devices and their platform solutions with easy-to-use and data analytics is supported by a strong team behind the company.

The founder, Li Jiang, received his PhD from the University of Wisconsin-Madison, was selected as an expert for China's National Thousand Talent Program, holds 23 US patents, and has served in senior management positions at high tech companies such as AMD, Spansion, etc. The opportunity to set up VivaLNK came from his experience of visiting the doctor in the US, where he was nearly misdiagnosed due to his heartbeat being slower than normal. misdiagnosed.

"The hospital was missing my usual ECG information, so it was difficult to make an accurate judgment. In the past few decades, the IT industry has been developing very fast, but the medical industry has been slow to feel the light of technology. I chose to devote myself to the digital healthcare industry in an instant." Dr. Li Jiang said.

Apple uses a cutthroat approach to team building, poaching people from multiple companies. But VivaLNK's approach to growing its team was less saber-rattling, and more a matter of getting things done. Take VivaLNK's medical consultant, Jeffery Olgin, a world-class cardiac electrophysiologist who loves Chinese food and said yes to joining VivaLNK after just one meal.

With the core underlying technology and a top-notch team, VivaLNK was introduced through the 5050 Overseas High-level Talent Entrepreneurship Program in Silicon Valley shortly after its inception, and settled in Hangzhou as a Class A key funded enterprise, and was awarded the title of National High-Tech Enterprise. Next, VivaLNK will continue to power the Chinese and global markets to provide complete IoT monitoring solutions for organizations and individuals.

Text | Yang Xue

WeChat | hhhh333yyyy

Please indicate when adding: Name - Company - Position

Send keywords in the background to get related good articles

Please contact authorization for reprinting on websites, public numbers, and so on

Recent Recommendations

<